Caitong International Asset Management’s Apyx Medical APYX Stock Holding History

Caitong International Asset Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55	Buy	+15	New	+$56	﹤0.01%	2008

Other funds holding APYX

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SEI Investments

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Caitong International Asset Management's APYX Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Apyx Medical (APYX) in Q1 2026: 15 shares worth $55. The stake represents ﹤0.01% of the portfolio and ranks #2008 among its holdings.

67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

Caitong International Asset Management held 15 shares of Apyx Medical worth $55 as of Q1 2026.
Apyx Medical was a new Caitong International Asset Management position in Q1 2026.
Apyx Medical made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2008 holding.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.